Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Phase III European trial results reinforce potential value of anti-LFA-1 MAb

Feb. 17, 1998

More data on HMR's malononitrilamides presented at scientific congress

Feb. 16, 1998

CDC advisory committee recommends rotavirus vaccine for routine use

Feb. 16, 1998

FDA approves CellCept for new indication

Feb. 16, 1998

SDZ-RAD: a novel immunosuppressant progresses in the Novartis pipeline

Feb. 13, 1998

NICHD develops experimental E. coli O157 vaccine

Feb. 13, 1998

Protein Sciences develops emergency vaccine against Hong Kong influenza

Feb. 9, 1998

Cytel and Baxter extend xenotransplantation agreement

Feb. 5, 1998

CBER completes review of Thymoglobulin PLA

Feb. 2, 1998

OspC-based Lyme disease vaccine proves effective in animal model of chronic disease

Feb. 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...